Combination therapies for the treatment of cancer
AssigneeErasca, Inc.
InventorsLeenus MARTIN, Leslie Harris BRAIL, Robert Field SHOEMAKER
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods of treating cancer with combination therapies of a SHP2 inhibitor and a KRAS G12C inhibitor.
Claims47
A method of treating a subject having cancer comprising administering to the subject a therapeutically effective amount of a compound of Formula I or its pharmaceutically acceptable salt:
- in combination with a KRAS inhibitor.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A kit comprising a compound of Formula I or a pharmaceutically acceptable salt thereof:
- and a KRAS inhibitor.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.